{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:17:00Z","timestamp":1778653020130,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40261-023-01318-y","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:02:39Z","timestamp":1699466559000},"page":"905-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-0932","authenticated-orcid":false,"given":"Julyana","family":"Medeiros Dantas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"de Jesus Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Alves Oliveira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1vio","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Serafim","family":"Dagostin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Campinho","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","volume":"35","author":"K Van Acker","year":"2009","unstructured":"Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206\u201313.","journal-title":"Diabetes Metab"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31:5\u201320.","journal-title":"Eur J Epidemiol"},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","volume":"8","author":"A Trikkalinou","year":"2017","unstructured":"Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8:120.","journal-title":"World J Diabetes"},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1533-2500.2008.00208.x","volume":"8","author":"IndINeP Study Group","year":"2008","unstructured":"IndINeP Study Group. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study. Pain Pract. 2008;8:362\u201378.","journal-title":"Pain Pract"},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3111\/200609055068","volume":"9","author":"J Tarride","year":"2006","unstructured":"Tarride J, Collet J, Choini\u00e8re M, Rousseau C, Gordon A. The economic burden of neuropathic pain in Canada. J Med Econ. 2006;9:55\u201368.","journal-title":"J Med Econ"},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341\u201350.","journal-title":"N Engl J Med"},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/dc17-2062","volume":"41","author":"ST Andersen","year":"2018","unstructured":"Andersen ST, Witte DR, Dalsgaard E-M, Andersen H, Nawroth P, Fleming T, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41:1068\u201375.","journal-title":"Diabetes Care"},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1526-4637.2011.01103.x","volume":"12","author":"MC DiBonaventura","year":"2011","unstructured":"DiBonaventura MC, Cappelleri JC, Joshi AV. Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Med. 2011;12:799\u2013807.","journal-title":"Pain Med"},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdiacomp.2014.10.013","volume":"29","author":"A Sadosky","year":"2015","unstructured":"Sadosky A, Mardekian J, Parsons B, Hopps M, Bienen EJ, Markman J. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. J Diabet Complicat. 2015;29:212\u20137.","journal-title":"J Diabet Complicat"},{"key":"1318_CR10","doi-asserted-by":"crossref","unstructured":"Vileikyte L, Gonzalez JS. Recognition and management of psychosocial issues in diabetic neuropathy. Handb Clin Neurol. Elsevier; 2014. p. 195\u2013209. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444534804000138","DOI":"10.1016\/B978-0-444-53480-4.00013-8"},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2337\/diacare.26.3.702","volume":"26","author":"HE Resnick","year":"2003","unstructured":"Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, et al. Diabetes and sleep disturbances. Diabetes Care. 2003;26:702\u20139.","journal-title":"Diabetes Care"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primer. 2019;5:41.","journal-title":"Nat Rev Dis Primer"},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.pain.2012.12.022","volume":"154","author":"N Torrance","year":"2013","unstructured":"Torrance N, Ferguson JA, Afolabi E, Bennett MI, Serpell MG, Dunn KM, et al. Neuropathic pain in the community: More under-treated than refractory? Pain. 2013;154:690\u20139.","journal-title":"Pain"},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S1474-4422(13)70193-5","volume":"12","author":"I Gilron","year":"2013","unstructured":"Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12:1084\u201395.","journal-title":"Lancet Neurol"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162\u201373.","journal-title":"Lancet Neurol"},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanp\u00e4\u00e4 M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113.","journal-title":"Eur J Neurol"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1155\/2014\/754693","volume":"19","author":"D Moulin","year":"2014","unstructured":"Moulin D, Boulanger A, Clark A, Clarke H, Dao T, Finley G, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the canadian pain society. Pain Res Manag. 2014;19:328\u201335.","journal-title":"Pain Res Manag"},{"key":"1318_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","volume":"98","author":"R Price","year":"2022","unstructured":"Price R, Smith D, Franklin G, Gronseth G, Pignone M, David WS, et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee. Neurology. 2022;98:31\u201343.","journal-title":"Neurology"},{"key":"1318_CR19","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. Statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021: n71.","journal-title":"BMJ"},{"key":"1318_CR20","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; 2022. Available from: www.training.cochrane.org\/handbook"},{"key":"1318_CR21","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"1318_CR22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","volume":"374","author":"I Gilron","year":"2009","unstructured":"Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. The Lancet. 2009;374:1252\u201361.","journal-title":"The Lancet"},{"key":"1318_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","volume":"3","author":"DA Simpson","year":"2001","unstructured":"Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis. 2001;3:53\u201362.","journal-title":"J Clin Neuromuscul Dis"},{"key":"1318_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","volume":"400","author":"S Tesfaye","year":"2022","unstructured":"Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet. 2022;400:680\u201390.","journal-title":"The Lancet"},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4065\/mcp.2010.0681","volume":"86","author":"RJ Tanenberg","year":"2011","unstructured":"Tanenberg RJ, Irving GA, Risser RC, Ahl J, Robinson MJ, Skljarevski V, et al. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc. 2011;86:615\u201326.","journal-title":"Mayo Clin Proc"},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002\u2013d4002.","journal-title":"BMJ"},{"key":"1318_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149\u201358.","journal-title":"Pain"},{"key":"1318_CR28","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1080\/14656566.2021.1909570","volume":"22","author":"K Pafili","year":"2021","unstructured":"Pafili K, Papanas N. Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy. Expert Opin Pharmacother. 2021;22:2267\u201380.","journal-title":"Expert Opin Pharmacother"},{"key":"1318_CR29","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","volume":"154","author":"S Tesfaye","year":"2013","unstructured":"Tesfaye S, Wilhelm S, Lledo A, Schacht A, T\u00f6lle T, Bouhassira D, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d\u2014a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154:2616\u201325.","journal-title":"Pain"},{"key":"1318_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","volume":"31","author":"DR Elbourne","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31:140\u20139.","journal-title":"Int J Epidemiol"},{"key":"1318_CR31","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3389\/fpsyg.2018.02089","volume":"9","author":"R Rosseland","year":"2018","unstructured":"Rosseland R, Pallesen S, Nordhus IH, Matre D, Bl\u00e5gestad T. Effects of sleep fragmentation and induced mood on pain tolerance and pain sensitivity in young healthy adults. Front Psychol. 2018;9:2089.","journal-title":"Front Psychol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-023-01318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T03:40:27Z","timestamp":1701920427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-023-01318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s40261-023-01318-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"12 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not Applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare they have no competing interests.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"J.D.M: conceptualization (lead), formal and statistical analysis (lead), bias analysis (equal), methodology (lead), writing - original draft preparation (equal).; M.J.O.: question validation (equal), data analysis (equal), writing - original draft preparation, review and editing (equal); S.B.: data extraction (equal), original draft preparation (equal), bias analysis (equal); L.A.O.S.: investigation (equal), data extraction (equal), data analysis (equal); C.S.D.: visualization (equal), writing - original draft preparation, review, and editing (equal); D.C.S.: validation (equal), supervision (lead), writing - review and editing (lead).","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors Contributions (CRediT)"}}]}}